Mapping of a Conformational Epitope on Plasminogen Activator Inhibitor-1 by Random Mutagenesis
Open Access
- 1 May 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (18) , 16329-16335
- https://doi.org/10.1074/jbc.m208420200
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid arteryBlood, 2000
- Course of molecular hemostatic markers during and after different surgical proceduresJournal of Clinical Anesthesia, 1999
- Regulation of Arterial Thrombolysis by Plasminogen Activator Inhibitor-1 in MiceCirculation, 1998
- PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular EventsThrombosis and Haemostasis, 1997
- Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal WomenNew England Journal of Medicine, 1997
- Immunoelectron Microscopic Localization of Plasminogen Activator Inhibitor Type 1 (PAI-1) in Smooth Muscle Cells from Morphologically Normal and Atherosclerotic Human ArteriesUltrastructural Pathology, 1997
- The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectinNature, 1996
- Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.Journal of Clinical Investigation, 1993
- Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.Proceedings of the National Academy of Sciences, 1992
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987